Centinel Spine Holdco (CNTL) files for IPO

October 7, 2026 4:34 PM EDT
(Updated - October 7, 2026 4:35 PM EDT)

Centinel Spine Holdco (CNTL) on Wednesday filed for a NYSE IPO.

The company describes itself as: "We are a commercial-stage medical technology company with a singular mission to transform spine surgery by advancing motion-preserving solutions for the cervical and lumbar spine. We are exclusively focused on Total Disc Replacement (TDR), which we believe represents a fundamentally different and increasingly important approach to spine surgery compared to traditional fusion techniques that permanently eliminate motion. Our prodisc platform is designed to improve the long-term quality of life for patients suffering from chronic neck and back pain while preserving the spine’s natural movement. As a pure-play company dedicated solely to TDR, we believe our depth of experience, exclusive focus, and long history of clinical success uniquely position us to lead the continued evolution of spine surgery toward solutions designed to preserve motion."

Morgan Stanley, Goldman Sachs, Piper Sandler, Canaccord Genuity and BTIG will serve as underwriters.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, IPOs

Related Entities

Goldman Sachs, Morgan Stanley, Canaccord Genuity, IPO, Maynard Um, BTIG, Mark Zuckerberg, ARK